SEC Form 4 · accession 0001178913-15-000942
ORAMED PHARMACEUTICALS INC. · ORMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nadav Kidron
Officer — President and CEO · Director · 10% Owner
Period of report
Mar 18, 2015
Accepted (ET)
Mar 20, 2015 · 9:22 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001176309
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 18, 2015 | P | 500 | $3.78 | A | 954,448 | D | |
| Common Stock | Mar 18, 2015 | P | 500 | $3.80 | A | 954,948 | D | |
| Common Stock | Mar 19, 2015 | P | 400 | $3.95 | A | 955,348 | D | |
| Common Stock | Mar 19, 2015 | P | 1,100 | $3.92 | A | 956,448 | D | |
| Common Stock | Mar 19, 2015 | P | 100 | $4.00 | A | 956,548 | D |
Table II — derivative securities
No Table II lines on this filing.